Lhasa Limited shared knowledge shared progress
Loading...
PublicationsJump to results
Authors
Publication Type
Publication Year
Related Products
Reset
New search
TitlePublishedTypeProducts
ICH M7: An Industry Perspective - ICH M7 India RoadshowsNovember 2018pdf file
Derek Nexus, Sarah Nexus and Vitic: How they fit into ICH M7 - ICH M7 India RoadshowsNovember 2018pdf fileDerek NexusSarah NexusVitic Nexus
Derek Nexus, The Expert System for ICH M7 - ICH M7 India RoadshowsNovember 2018pdf fileDerek Nexus
An adverse outcome pathway framework to support developmental and reproductive toxicity risk assessmentsNovember 2018pdf fileDerek NexusSarah NexusVitic Nexus
A Defined Approach for Predicting Skin Sensitisation Hazard and PotencyNovember 2018pdf fileDerek Nexus
Mirabilis 3.1.1 Windows Installation GuideNovember 2018pdf fileMirabilis
Mirabilis 3.1.1 Linux Installation GuideNovember 2018pdf fileMirabilis
Mirabilis 3.1.1 Release NotesNovember 2018pdf fileMirabilis
Important considerations for the validation of QSAR models for in vitro mutagenicityNovember 2018Derek NexusSarah NexusVitic Nexus
Vitic 3.1 Installation GuideOctober 2018pdf fileVitic Nexus
Zeneth: an in silico tool to aid identification of degradantsOctober 2018pdf fileZeneth
Webinar - A defined approach for predicting skin sensitisation hazard and potency.October 2018
Improvement of quantitative structure–activity relationship (QSAR) tools for predicting Ames mutagenicity: outcomes of the Ames/QSAR International Challenge ProjectOctober 2018Derek NexusSarah Nexus
Extrapolation of in vitro structural alerts for mutagenicity to the in vivo endpointOctober 2018Derek Nexus
In Silico Predictions For GenotoxicityOctober 2018pdf fileDerek NexusSarah Nexus
Webinar - Mirabilis: Controlling potential genotoxic impurities encountered during API synthesisOctober 2018Mirabilis
Integrating Knowledge Of Carcinogenicity Adverse Outcome Pathways (AOPs) With Experimental DataOctober 2018pdf fileDerek NexusVitic Nexus
Interpreting the Sensitivity and Equivocal Settings in Sarah NexusOctober 2018pdf fileSarah Nexus
Meeting report, ICH M7 relevant workshop: use of (Q)SAR systems and expert judgmentSeptember 2018pdf fileDerek NexusSarah Nexus
Development Of A Network Of Adverse Outcome Pathways (AOPs) For CarcinogenicitySeptember 2018pdf fileVitic NexusDerek NexusSarah Nexus
Quantifying Degree of Aromaticity from Structural FeaturesSeptember 2018pdf fileVitic Nexus
Prediction of water solubility of organic compounds using Lhasa in-house descriptorsSeptember 2018pdf file
Chapter 17: In Silico Drug Degradation PredicitonSeptember 2018Zeneth
An adverse outcome pathway framework to support the assessment of DART liabilities of compoundsSeptember 2018pdf fileDerek Nexus
How low can you go? An analysis of lowest effective dose in the Ames test.September 2018pdf fileVitic Nexus

© 2019 Lhasa Limited | Registered office: Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK Tel: +44 (0)113 394 6020
VAT number 396 8737 77 | Lhasa Limited is registered as a charity (290866)| Company Registration Number 01765239 (England and Wales).

Thanks to QuestionPro's generosity, we now have survey software that powers our data intelligence.